Moreover, LCN2 is frequently upregulated in diverse cancers and has been linked to EMT, invasion, angiogenesis, and modulation of the tumor microenvironment, including interactions with myeloid cells and neutrophils (30, 31). The gene discussed is LCN2; the disease is neoplasm.